<DOC>
	<DOCNO>NCT00518973</DOCNO>
	<brief_summary>This research study hold UCSD determine whether medication Quetiapine help people suffer anorexia nervosa reduce core eating disorder symptoms . This study see medication Quetiapine help symptom anxiety , depression , obsessionality , addition increase BMI . Men woman age 18-65 currently suffer anorexia nervosa need .</brief_summary>
	<brief_title>Trial Quetiapine Anorexia Nervosa</brief_title>
	<detailed_description />
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Meet criterion DSMIV anorexia nervosa ( restrict bingeeating/purging type ) At least 15 % ideal body weight Judged reliable keep clinic visit able take test examination require protocol able understand decide whether sign Informed Consent . Subjects include study present following : Schizophrenia schizoaffective disorder ( DSMIV ) Any ECG abnormality consider clinically significant investigator Subjects liver enzymes elevate two time normal Other laboratory abnormality consider clinically significant investigator include laboratory deviation require acute medical intervention Pregnant woman , woman childbearing potential use medically accept mean contraception ( abstinence , IUD , birth control pill , barrier device implant progesterone rod stabilize least three month ) , lactate woman Serious suicide risk Any medical condition would preclude outpatient treatment anorexia nervosa use quetiapine Organic brain disease History severe allergy Multiple adverse drug reaction know allergy quetiapine Use neuroleptic medication ( except benzodiazepine ) within 7 day precede randomization History alcohol substance abuse disorder define DSMIV within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>